Pieris Pharmaceuticals Stock Technical Analysis
PIRS Stock | USD 11.93 0.07 0.58% |
As of the 24th of April, Pieris Pharmaceuticals holds the Coefficient Of Variation of (7,305), variance of 21.02, and Risk Adjusted Performance of 1.0E-4. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pieris Pharmaceuticals, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Pieris Pharmaceuticals, which can be compared to its competitors. Please check Pieris Pharmaceuticals coefficient of variation and value at risk to decide if Pieris Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 11.93 per share. Given that Pieris Pharmaceuticals has information ratio of (0.03), we recommend you to check out Pieris Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.
Pieris Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pieris, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PierisPieris |
Pieris Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
7.0 | Hold | 1 | Odds |
Most Pieris analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pieris stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pieris Pharmaceuticals, talking to its executives and customers, or listening to Pieris conference calls.
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Pieris Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pieris Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Pieris Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Pieris Pharmaceuticals. You can use it to identify possible trend reversals for Pieris Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pieris Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Pieris Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Pieris Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0026 , which may suggest that Pieris Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.26, which is the sum of squared deviations for the predicted Pieris Pharmaceuticals price change compared to its average price change.About Pieris Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pieris Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pieris Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pieris Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Pieris Pharmaceuticals. By analyzing Pieris Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pieris Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pieris Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 38.49 | 81.87 | 51.49 | 42.39 | PTB Ratio | 4.81 | 2.76 | 0.61 | 0.58 |
Pieris Pharmaceuticals April 24, 2024 Technical Indicators
Most technical analysis of Pieris help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pieris from various momentum indicators to cycle indicators. When you analyze Pieris charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 1.0E-4 | |||
Market Risk Adjusted Performance | (0.07) | |||
Mean Deviation | 3.07 | |||
Coefficient Of Variation | (7,305) | |||
Standard Deviation | 4.59 | |||
Variance | 21.02 | |||
Information Ratio | (0.03) | |||
Jensen Alpha | (0.15) | |||
Total Risk Alpha | (0.70) | |||
Treynor Ratio | (0.08) | |||
Maximum Drawdown | 33.39 | |||
Value At Risk | (5.42) | |||
Potential Upside | 5.91 | |||
Skewness | 2.37 | |||
Kurtosis | 11.32 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pieris Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Pieris Stock analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Pieris Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pieris Pharmaceuticals. If investors know Pieris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pieris Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.60) | Revenue Per Share 38.026 | Quarterly Revenue Growth (0.78) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Pieris Pharmaceuticals is measured differently than its book value, which is the value of Pieris that is recorded on the company's balance sheet. Investors also form their own opinion of Pieris Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pieris Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pieris Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pieris Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pieris Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pieris Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pieris Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.